home / stock / bivi / bivi news

BIVI News and Press, BioVie Inc. From 05/10/21

Stock Information
Company Name: BioVie Inc.
Stock Symbol: BIVI
Market: NASDAQ
Website: biovieinc.com
Menu
BIVI BIVI Quote BIVI Short BIVI News BIVI Articles BIVI Message Board
Get BIVI Alerts

News, Short Squeeze, Breakout and More Instantly...
BIVI - BioVie Announces Amended Terms for Asset Acquisition from Privately Held NeurMedix

SANTA MONICA, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for chronic debilitating liver diseases, today announced amendments to certain terms for the previously announced acquisit...
BIVI - PINS, CLOV, ENPH and PBI among midday movers

Gainers: Brooklyn ImmunoTherapeutics (BTX) +44%.Uxin (UXIN) +25%.Ashford Hospitality Trust (AHT) +24%.Boxlight (BOXL) +21%.ADMA Biologics (ADMA) +18%.Clover Health Investments (CLOV) +16%.Unitil (UTL) +15%.Pitney Bowes (PBI) +15%.ClearSign Technologies (CLIR) +15%.Microvision (MVIS) ...

BIVI - ADMA Biologics, Brooklyn ImmunoTherapeutics leads healthcare gainers; Protalix BioTherapeutics, Benitec Biopharma among major losers

Gainers: ADMA Biologics (ADMA) +25%, Brooklyn ImmunoTherapeutics (BTX) +23%, Clover Health Investments (CLOV) +15%, Neptune Wellness Solutions (NEPT) +12%, Akouos (AKUS) +11%.Losers: Protalix BioTherapeutics (PLX) -40%, Benitec Bioph...

BIVI - BioVie to Present at 2021 B. Riley Securities' Neuroscience Conference

SANTA MONICA, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of liver disease and, pending closing of the announced transaction with NeurMedix, neurological and ne...
BIVI - BioVie acquires biopharma assets from private company NeurMedix

BioVie (BIVI) trades 7.1% higher after hours on acquiring biopharmaceutical assets of NeurMedix, a San Diego based privately held clinical-stage pharmaceutical company focused on novel therapeutic assets for the treatment of neurodegenerative and neurological disorder...

BIVI - BioVie Acquires Biopharma Assets from Privately Held NeurMedix

Includes Pivotal Phase 3 Alzheimer’s Asset NE3107 Cuong V. Do Named CEO of The New BioVie Conference Call Scheduled for April 27, 2021 at 5:00PM EDT SANTA MONICA, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or ...

BIVI - INO, OCGN, QDEL and MVIS among midday movers

Gainers: Sypris Solutions (SYPR) +75%.Ocugen (OCGN) +41%.Brooklyn ImmunoTherapeutics (BTX) +34%.MicroVision (MVIS) +32%.BioVie (BIVI) +29%.FreightCar America (RAIL) +27%.Uxin (UXIN) +26%.Birks Group (BGI) +24%.Meridian Bancorp (EBSB) +21%.22nd Century (XXII) +20%.Losers: I...
BIVI - Ocugen, Brooklyn ImmunoTherapeutics leads healthcare gainers; Inovio Pharmaceuticals, Protara Therapeutics among major losers

Gainers: Ocugen OCGN +24%, BioVie (BIVI) +16%, Brooklyn ImmunoTherapeutics (BTX) +20%, 22nd Century (XXII) +12%, Jaguar Health (JAGX) +7%.Losers: Inovio Pharmaceuticals INO -28%, Protara Therapeutics TARA -19%, EDAP TMS EDAP -13%,&#x...

BIVI - SKLZ, LAZR, NFLX and DGLY among midday movers

Gainers: Welbilt (WBT) +40%.Timber Pharmaceuticals (TMBR) +35%.Skillz (SKLZ) +27%.Asensus Surgical (ASXC) +27%.inTEST (INTT) +24%.Mogo (MOGO) +20%.GreenBox POS (GBOX) +20%.MicroVision (MVIS) +20%.BioVie (BIVI) +19%.Luminar Technologies (LAZR) +19%.Losers: Unique Fabricating (UF...

BIVI - U.S. IPO Week Ahead: The Spring IPO Market Starts To Thaw In An 8 IPO Week

The IPO market starts to pick back up with eight IPOs scheduled to raise $2.2 billion in the week ahead. Street research is expected for one company on Sunday, 3/14. Lock-up periods will be expiring for 15 companies. For further details see: U.S. IPO Week Ahead: The Spri...
Previous 10 Next 10